Prevention of steatohepatitis by pioglitazone: Implication of adiponectin-dependent inhibition of SREBP-1c and inflammation
- 25 December 2008
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 50 (3) , 489-500
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- The Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone Represses Inflammation in a Peroxisome Proliferator-Activated Receptor-α–Dependent Manner In Vitro and In Vivo in MiceJACC, 2008
- XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel DiseaseCell, 2008
- Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient dietJournal of Lipid Research, 2008
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein KinaseJournal of Biological Chemistry, 2007
- AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA ribosideBiochemical Journal, 2007
- Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disordersThe Journal of Physiology, 2006
- Metformin Prevents Alcohol-Induced Liver Injury in the Mouse: Critical Role of Plasminogen Activator Inhibitor-1Gastroenterology, 2006
- Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in miceJournal of Hepatology, 2004
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003